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Abstract
Introduction Malnutrition is a common and under-recognized
problem in cancer patients. It has been correlated to a large
number of physical, psychological, and clinically relevant
adverse effects in oncology patients, including impaired
tolerance to anticancer therapy, adverse reactions, and reduced
quality of life. Consequently, tailored strategies to identify
patients at nutritional risk are essential to implement nutri-
tional support effectively and to reduce cancer morbidity.
Purpose of a nutritional screening tool A screening tool
should be an easy, standardized, rapid, noninvasive, and
cost-effective diagnostic tool to identify cancer patients at
nutritional risk in daily clinical practice. If patients at risk
for malnutrition are identified early, many cases may be
treated or prevented, with beneficial effects on patient
outcome and subsequent reductions of health care costs.
Screening tools This article discusses the Malnutrition
Universal Screening Tool, the Nutritional Risk Screening,
the Mini Nutritional Assessment—Short Form®, the scored
Patient-Generated Subjective Global Assessment (PG-SGA),
and the Malnutrition Screening Tool (MST) in an oncology
setting.
Conclusions Clinical institutions should implement an
appropriate and validated screening tool and assessment
protocol, which should contain an action plan. To date, the
MST and the PG-SGA are the best validated screening tools
for use in oncology patients. The PG-SGA is an assessment
tool with screening components, whereas the MST is a pure
screening tool and, therefore, quick and easy to use for
trained as well as untrained staff. Further validation of all
nutrition screening tools is needed, as well as further
research to evaluate the benefits of nutrition screening and
support with regard to outcomes.
Keywords Nutritional screening tools . Daily clinical
practice . Cancer . Oncology patients . Malnutrition
Introduction
Decline in nutritional status and continuing weight loss may
have deleterious consequences for oncology patients. The
prevalence of cancer-related malnutrition ranges from 30%
to 64% in inpatients and is related to an increased risk for
adverse clinical outcome [1–7], poor quality of life, and
lower survival rates [8–10]. In addition, as many as 20% of
cancer patients die from the effects of malnutrition rather
than from the malignancy [11]. Nutritional status tends to
deteriorate during the course of hospitalization [12] and
malnutrition is associated with increased morbidity and
mortality, prolonged hospital stay, and increased health care
costs [13, 14]. Moreover, malnutrition worsens the respon-
siveness and the tolerance to anticancer therapy [15]. On
the other hand, early and adequate provision of nutritional
support for those identified as malnourished has been
demonstrated to improve outcome [16, 17]. It is, therefore,
essential that nutritional issues be addressed at the time of
diagnosis and throughout the course of cancer care.
Proactive nutritional screening and intervention are the
cornerstones of success in preventing symptoms of malnu-
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trition. If patients at risk for malnutrition are identified
early, they can be treated or malnutrition may even be
prevented. The medical staff in charge of a patient should
perform the nutritional risk screening to identify nutrition-
related problems and to solve them with an interdisciplinary
approach. One study demonstrated that up to 52% of
malnourished patients were not identified based on their
nutritional documentation, suggesting that the problem is
commonly overlooked by physicians [12].
First-line strategies must include routine screening and
identification of inpatients or outpatients at nutritional risk
with the use of a simple and standardized screening tool.
There is agreement among international nutrition organiza-
tions and accredited health care organizations that routine
nutritional screening should be a standard procedure for
every patient admitted to a hospital [18–20]. In the absence
of formal screening procedures, more than half of the
patients at risk for malnutrition do not appear to be
identified and/or are not referred for treatment [20]. It is
mandatory to identify patients at nutritional risk who can
profit from adequate and rapid nutritional support. However,
it is a reality that nutritional screenings are not standard care in
many institutions. There is no “gold standard” to detect
malnutrition. Numerous validated screening tools are avail-
able and appropriate for the inpatient and/or outpatient. For
clinicians, it is important to know for which population and
care setting a tool was designed and to decide if a specific tool
may be appropriate for their institution.
Purpose of a nutritional screening tool
The guidelines of the European Society for Clinical
Nutrition and Metabolism (ESPEN) state that nutritional
screening should be able to predict the clinical course based
on nutritional status and whether patients could benefit
from nutritional treatment [19]. Commonly requested
criteria for a screening tool are that it is simple to conduct
by medical staff or community health care teams and that it
is noninvasive as well as quick to perform (<5 min). It
should not involve calculations or include laboratory data
and it should be easily interpretable, inexpensive, and
reproducible [21, 22]. Moreover, it should be sensitive
enough to detect all or nearly all patients at nutritional risk.
There are some advantages in registering disease severity as
well as nutritional status, since they interact.
In the community, malnutrition, with or without chronic
disease, may be the primary factor determining the mental
or physical functioning of an individual, whereas in the
clinical setting, disease factors assume greater importance,
with disease-associated malnutrition assuming an important
even though secondary role [19]. In hospitals, further
aspects of a disease have to be considered in combination
with nutritional measurements in order to determine
whether nutritional support is likely to be beneficial.
The predictive validity of a screening method is of major
importance—i.e., that the individual identified to be at risk
by the method is likely to benefit from nutritional
intervention initiated as a consequence of it. Furthermore,
the screening tool must also have a high degree of content
validity—i.e., taking into consideration all relevant compo-
nents of the problem it is meant to solve. In addition, the
tool must have high reliability (little inter-observer varia-
tion), it must be practical, and it should not contain
redundant information. Finally, a screening tool should be
linked to a specified protocol for action, such as referral of
patients at risk to an expert for more detailed assessment
and for determination of the appropriate nutritional inter-
vention. Following nutritional screening, patients at risk
should get a more in-depth nutritional assessment. The
assessment should be a detailed examination of metabo-
lism, nutritional status, body composition, and functional
variables. It is a more extensive process than the screening
and it leads to an appropriate nutritional care plan which
takes into consideration indications, possible negative
effects of malnutrition, and in some cases, special feeding
techniques.
Components of nutritional screening
Screening tools are planned to detect protein and energy
malnutrition and/or to predict whether malnutrition is likely
to develop or deteriorate under the present and future
circumstances affecting the patient. Therefore, screening
tools should answer the following four questions [19]:
(a) What is the patient's current condition? Height and
weight allow the calculation of the body mass index
(BMI). Whenever it is not possible to obtain height
and weight, e.g., in severely ill patients, a useful
surrogate may be mid-arm circumference [23].
(b) Is the condition stable? Recent weight loss and
information on weight changes are obtained from a
patient history or from previous measurements in
medical records (recent weight loss).
(c) Is the condition likely to get worse? This question may
be answered by asking whether food intake has been
decreased up to the time of screening (recent food
intake).
(d) Is the disease process likely to negatively affect
nutritional status? In addition to decreasing appetite,
the disease process may increase nutritional requirements
due to stress metabolism associated with severe disease.
All screening tools should answer questions a–d for both
inpatients and outpatients. A single BMI cut-off value is not
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sufficient for the detection of malnutrition; in particular,
knowing if there has been recent weight loss over time
helps to identify patients at risk for malnutrition and seems
to be the most important single indicator of nutritional
status [24]. Therefore, nutritional screening tools should use
both BMI and weight loss to predict risk for malnutrition.
All those variable parameters are key determinants of
cancer patients' quality of life. Ravasco et al. [25] stated
that cancer stage and location were the major determinants
of patients' quality of life globally, but there were some
diagnoses for which the impact of nutritional deterioration
(30%) combined with deficiencies in nutritional intake
(20%) may be more important than the stage (1%) or
location (30%) of the cancer. A number of screening tools
use further variables, such as gastrointestinal symptoms
(nausea, diarrhea, and constipation), pain, and fatigue,
which can also impact nutritional status and deterioration.
In fact, these parameters have a high specificity (91.1%) but
a relatively low sensitivity (43.3%); therefore, more than
half of patients who will become malnourished in the future
are not categorized as being at high nutritional risk [22].
Screening tools
The ESPEN recommends the following nutritional
screening tools [19]: the Malnutrition Universal Screening
Tool (MUST), the Nutritional Risk Screening (NRS-
2002), and the Mini Nutritional Assessment® (MNA®)
method. This review further includes the Mini Nutritional
Assessment—Short Form® (MNA-SF®), the Subjective
Global Assessment (SGA), the scored Patient-Generated
Subjective Global Assessment (PG-SGA), and the Malnu-
trition Screening Tool (MST).
Malnutrition Universal Screening Tool (MUST) for adults
The purpose of the MUST system is to detect adults who
are at risk for malnutrition or who are malnourished on
the basis of knowledge about the association between
impaired nutritional status, body composition, and phys-
ical function (Fig. 1) [26, 27]. It was developed by the
Malnutrition Advisory Group, a standing committee of the
British Association for Parenteral and Enteral Nutrition
[26, 28].
The MUST is recommended by ESPEN as the preferred
screening tool for patients in the community, which is the
setting for which it was primarily developed. In community
care, it predicts rate of hospital admissions and the number
of visits to general practitioners. Furthermore, it predicts
clinical outcome [29]. The MUST is associated with high
reproducibility among health care providers and is inter-
nally consistent and reliable [28]. It was validated in a
range of health care settings (i.e., primary care, home care,
acute care, long-term care) by health care providers of
various professions and can be applied to adult patients of
various ages [27].
Three independent criteria are used by MUST to
determine the overall risk for malnutrition: current weight
status using BMI, unintentional weight loss, and acute
disease effect that induced a phase of nil per os for >5 days.
Each parameter can be rated as 0, 1, or 2. Overall risk for
malnutrition is established as low (score=0), medium
(score=1), or high (score≥2). Each of these three criteria
can independently predict clinical outcome, varying by the
clinical circumstance, but together the three criteria are
better predictors than each by itself [27].
The predictive validity of MUST in the community is
based on previous and new studies on the effect of
semistarvation/starvation on mental and physical function
in healthy volunteers. Moreover, MUSTwas documented to
have a high degree of reliability (low inter-observer
variation), with a κ=0.88–1.00. Its content validity was
established by a multidisciplinary working group in its
development. Its practicability was documented in a
number of studies in different community regions in the
United Kingdom [26, 27].
 
In the last 
3-6 months 
 
  Percent          score 
     5%                0 
   5-10%               1 
  10%              2
 
 
 
 Add scores 
 Body Mass 
Index 
(kg/m2) 
  Weight 
loss 
(unintentional) 
 
Disease 
effect 
(acute) 
BMI (kg/m2)    score 
        ≥
≤ ≥
≤
 20.0           0 
 18.5 - 20.0           1 
 18.5           2 
There has been or is 
no nutritional intake 
for > 5 days 
 
add a score of 2 
  
score        risk        MEASURE             implement 
 
      0             low              ROUTINE                    Hospital:        screening every week 
                                   CLINICAL CARE          Care Homes: screening every month 
                                                                              Community:   screening every year 
 
      1          medium          OBSERVE                  Hospital & Care Homes: document 
                                                                              dietary and fluid intake for three days 
                                                                              Community: repeat screening (1-6 months) 
 
    ≥ 2            high               TREAT                    Hospital & Care Homes & Community: 
                                                     Nutritional assessment, and implement 
                                                                             local policies →  sequence: A. food selection,
                                                                                 B. food fortification, C. oral supplements 
Overall risk of malnutrition 
Fig. 1 MUST for adults [26]
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Nutritional Risk Screening (NRS-2002)
The NRS-2002 is a screening tool introduced by
Kondrup et al. and an ESPEN working group in 2003
(Fig. 2). This tool was validated against 128 controlled
nutrition support trials to evaluate whether it was able to
distinguish patients with a positive clinical outcome due to
nutrition intervention from those who showed no benefit
of nutritional support [30]. The ESPEN recommends the
NRS-2002 as the preferred screening tool for hospitalized
patients (mixed population). It has been well accepted
within Europe. It contains all the components of the
MUST and, in addition, a grading of severity of disease as
a reflection of increased nutritional requirements. It
includes four questions as a prescreening for departments
with fewer patients at risk. With the prototypes for
severity of disease given, it is meant to cover all possible
patient categories in a hospital.
The NRS-2002 is an easy-to-use tool that is quick to
complete (2–3 min) [31]. In a study of 750 newly
admitted patients, it was possible to screen 99% of the
patients. This demonstrates the practicality and usefulness
of this tool in hospitalized patients [32]. The NRS-2002
classifies the patient's nutritional status in four categories
based on BMI, percentage of recent weight loss, recent
change in food intake, and disease severity. Each category
can be classified as normal (score=0), mild (score=1),
moderate (score=2), or severe (score=3). The prototypes
for severity of disease are:
Score=1—a patient with chronic disease admitted to
the hospital due to complications. The patient is weak
Fig. 2 NRS-2002 [30]
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but out of bed regularly. Protein requirements are
increased, but can be covered by oral food or supple-
ments in most cases.
Score=2—a patient confined to bed due to illness, e.g.,
following major abdominal surgery. Protein require-
ments are substantially increased, but can be covered,
although artificial feeding is required in many cases.
Score=3—a patient in intensive care with assisted
ventilation, etc. Protein requirements are increased and
cannot be covered even by artificial feeding. Protein
breakdown and nitrogen loss can be significantly
attenuated.
Age contributes one point if the patient is ≥70 years old.
The sum of the nutritional score (0–3), severity of disease
score (0–3), and age adjustment (≥70 years: score +1) can
range from 0 to 7. Patients are classified as at no risk with a
score <3 and as at nutritional risk with a score ≥3.
The NRS-2002 is used to predict outcome based on risk
parameters identified in the nutritional assessment. Its
predictive validity was documented by applying it in a
retrospective analysis of 128 randomized controlled trials,
as mentioned above [30]. Subsequently, when applied
prospectively in a controlled trial with 212 hospitalized
patients who received nutritional intervention based on this
screening method, the length of hospital stay was reduced
by 6 days among patients with complications who received
intervention vs. those who received no nutritional interven-
tion (p=0.015) [33]. Its reliability was validated by inter-
observer variation among a nurse, a dietician, and a
physician, with a κ=0.67 and with a κ=0.76 among
physicians [3, 30].
Mini Nutrition Assessment® (MNA®) and MNA—Short
Form® (MNA-SF®)
The MNA® is another rapid and efficient nutrition
assessment tool (http://www.mna-elderly.com/) [34]. It
was developed to assess nutritional status as part of the
standard evaluation of elderly patients or otherwise frail
individuals in nursing homes and hospitals [35]. The
MNA® website gives instructions on the use of this tool
[36].The MNA® was validated using two principal criteria:
(a) clinical status, which consists of a nutrition assessment
conducted independently by physicians trained in nutrition
on the basis of the subject's clinical record, and (b)
comprehensive nutrition assessment, which includes a
complete assessment of anthropometrics, biochemical
markers, and dietary intake according to the Survey in
Europe on Nutrition and the Elderly, a Concerted Action
study [37].
The full MNA® includes 18 items grouped into four
rubrics: anthropometric assessment (items B, F, Q, and R),
general assessment (items C, D, E, G, H, and I), short
dietary assessment (items A, J, K, L, M, and N), and
subjective assessment (items O and P). Each answer has a
numerical value and contributes to the final score, which
reaches a maximum of 30. A cumulative score on the
MNA® of ≥24 indicates a well-nourished state, 17–23.5
indicates a risk for malnutrition, and <17 indicates
malnutrition. For the MNA® total score, the inter-observer
variation was estimated with a κ=0.51 [38].
The MNA-SF® was developed and validated to allow a
two-step screening process in low-risk populations that
retains the validity and accuracy of the full MNA® [39].
The MNA-SF® uses the six strongly correlated items, and
the maximum score of the MNA-SF® is 14. Scores ≥12
indicate satisfactory nutritional status, with no further
requirement for intervention. An MNA-SF® screening
score ≤11 suggests risk for malnutrition. Confirmation is
obtained by completing the full MNA® questionnaire
(assessment part). The group of Sieber et al. stated in a
trial that the MNA® is only feasible in 65% of geriatric
patients with acute illness [40]. Compared to this, with the
NRS-2002, almost all patients (99%) could be screened
[40]. It takes about 4 min to administer the MNA-SF® and
about 15 min for the full MNA® [41]; in the context of
limited human resources, this is a further disadvantage.
Subjective Global Assessment (SGA) and Patient-Generated
SGA (PG-SGA)
The SGA was developed by Detsky et al. in 1987 [42]
using a questionnaire that contains medical history and
clinical findings items (weight loss, changes in dietary
intake, gastrointestinal symptoms, presence of symptoms
that can influence nutritional intake, functional capacity, a
nutrition-related physical examination, and the clinicians'
overall judgment of the patient's nutritional status). The
SGA is an assessment tool rather than a screening tool; it
has been used in a wide variety of health care settings and
has been shown to have superior sensitivity and specificity
compared to usual parameters of nutritional assessment,
such as albumin [43]. Moreover, the SGA is efficient, cost-
effective, easy to learn, and showed a high degree of inter-
rater agreement [42]. The negative aspect of this tool is the
professional resistance to perform the physical exam and
the perception of additional workload. The most time-
consuming aspect of the SGA for the clinician is the patient
history section.
In 1994, the SGA was adapted by Ottery to more
specifically meet the needs of the cancer patient, with
increases in the gastrointestinal symptom section to include
the nutritionally determinant symptoms found in the
oncology population (PG-SGA) [11, 44]. In addition, the
patient can complete the history section to make the process
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more efficient and patient-involved [45]. In 2002, Bauer et
al. added scoring and triage components [46]. The resulting
tool, the scored PG-SGA, was validated for use in cancer
patients [46].
Some studies have shown a close correlation between
the scored PG-SGA and weight loss in the previous
6 months [46, 47], length of hospital stay [46], quality of
life [47], and energy intake [48]. Moreover, the use of the
PG-SGA streamlines nutritional assessment in the clinical
oncology setting, involves the patient directly but in an
efficient manner, and allows the clinician to spend the
limited time available addressing the problems identified
rather than gathering information. The PG-SGA simplifies
the identification of specific nutritional intervention; it
facilitates quantitative outcome data collection, and this
tool is specifically useful and validated in a clinical
oncology setting. Additionally, the PG-SGA can be used
to predict the need of nutritional intervention and more
importantly the potential benefit from intensive nutritional
support. The tool has the following practical disadvantages:
– Training is required to score the patient-generated
section, as well as to complete the clinical assessment
portion of the PG-SGA [49, 50];
– The SGA does not allow for the categorization of mild
malnutrition and focuses on chronic or established
rather than on acute nutritional changes [51, 52];
– The SGA more accurately identifies established mal-
nutrition. Concerning nutritional risk, its sensitivity is
suboptimal [53, 54];
– The SGA may just as well represent an index of
sickness rather than nutrition [55];
– The PG-SGA includes calculations of percent change
in body weight and a nutrition-related physical exam,
both of which are time-consuming.
Despite the mentioned drawbacks of the PG-SGA as a
screening tool, it is still the tool most widely used and most
accepted for nutritional assessment in cancer patients [10,
45, 56–58].
The current guidelines of the American Society for
Parenteral and Enteral Nutrition and ESPEN recommend
the SGA for the assessment of nutritional status [18, 59].
Malnutrition Screening Tool (MST)
The MST, developed by Ferguson et al. in 1999, is a short and
easy screening tool (Fig. 3) [22]. MST combines questions
regarding appetite and recent unintentional weight loss with
the highest specificity and sensitivity at predicting the SGA
result scores. The MST has been validated in inpatients and
in oncology outpatients receiving radiotherapy [22, 60].
Recently, Isenring et al. compared the tool to the PG-SGA in
outpatients receiving chemotherapy and found that the MST
was a strong predictor of risk for malnutrition relative to the
PG-SGA (see Table 1) [47]. The MST seems to be a quick
and easy screening tool which is well-validated in oncology
inpatients and outpatients.
Validations of screening tools in the oncology population
Many tools have been developed to screen for malnutrition,
but only a few have been validated in oncology patients.
Table 1 provides a survey of key studies addressing
malnutrition screening in this setting.
The MUST seems not to be the tool of choice in
cancer patients because it lacks sensitivity and specificity
for this population [61]. Roulston et al. confirmed this
finding, reporting that the MUST failed to identify 61.5%
of patients considered to be at risk for malnutrition
(compared with a full nutritional assessment by an
oncology dietitian), whereas the MNA and the MST were
capable of correctly identifying cancer patients at risk for
malnutrition [62]. On the other hand, Amaral et al. stated
that the MUST showed the highest agreement with the
NRS-2002 in hospitalized cancer patients [4]. Further-
more, it accurately identified patients at risk for longer
length of hospital stay [4]. In this study, the MST
presented the highest specificity and positive predictive
values of 78.3%, but a low sensitivity [4].
According to a study by Kyle et al. [53], which
compared various screening tools to the SGA in a mixed
hospitalized population, the NRS-2002 was associated with
higher sensitivity and specificity and higher positive and
negative predictive values than the MUST; the NRS-2002 is
a better screening tool than MUST in the hospital setting
compared to SGA, but not well-validated in cancer patients.
These findings agree with the study of Amaral et al. [4].
The NRS-2002 was validated by several studies in both
medical and surgical patients. In a randomized controlled
trial in a mixed population (n=212; 19% oncology
patients), Johansen et al. showed a risk for nutrition-
related worsened outcome if untreated [33]. In another
international, multicenter trial (n=5,018, mixed population;
about 20% oncology patients), an NRS-2002 score≥3 was
shown to be significantly related to longer hospital stay and
to higher complication and mortality rates, also after
adjustment for confounders [3]. The study by Schiesser et
al. demonstrated that the NRS-2002 was successful in
predicting postoperative complications in 608 patients
undergoing elective gastrointestinal surgery for benign
diseases and malignancy (22.3%) [66]. The authors
reported a nutritional risk prevalence of 40% in the cancer
patients. In a recent trial from our research group, we
showed that the nutritional risk determined by the NRS-
2002 is a significant clinical predictor of postoperative
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complication rate and shows a positive trend in predicting
mortality [63].
Although the MNA® and the MNA-SF® tools have been
used in oncology patients, there is limited evaluation in the
oncology population [49, 56, 67]. There are a number of
questions that relate to dietary intake, but none of them
consider nutritional impacts specific to cancer. Moreover,
there are no intervention guidelines. Furthermore, the
sensitivity of the MNA® in analyzing an unintentional
weight loss of >10% over 3 months was merely 33% [56],
and the positive predictive value in oncology patients was
limited, at 59% [49].
Read et al. compared the MNA® and the PG-SGA in an
oncology setting. Both tools were able to correctly classify
patients as malnourished, although the MNA® lacked
specificity [49]. This indicates that the MNA® categorizes
some patients as requiring nutritional support when actually
they do not. The MNA® contents determinants of nutri-
tional status, which included, for example, the use of more
than three medications and the number of full meals taken
per day. If patients receive more than three medications or
eat fewer than three full meals, which is frequently the case
for oncological patients, they are penalized with points
deducted from the score and are wrongly categorized as
being at risk for malnutrition or malnourished.
Bauer et al. compared the MNA® and the NRS-2002
in a geriatric population with acute illness at hospital
admission and stated that the MNA® appears to be more
appropriate for the community-dwelling elderly [40]. The
NRS-2002 offers advantages in the hospital setting (e.g.,
simple and quicker).
In addition, the MNA-SF® requires further validation
and reliability testing in oncology patients. The current
diagnostic indicators of this tool may need further adapta-
tion for cancer patients. The PG-SGA is the most studied
and most commonly accepted system for an accurate
nutritional assessment of oncology patients. However, it is
an assessment rather than a quick and easy screening tool. It
 
 Questions 
 
Score 
 
 1. Have you lost weight recently without trying? 
   No
   Unsure
   If yes, how much weight (kg) have you lost? 
   1-5 1  
   6-10 2  
   11-15 3  
   16-20 4  
   Unsure 2  
2  
 Weight loss score = 
 
 
 2. Have you been eating poorly because of decreased appetite? 
   No 0  
0  
   Yes 1  
 Appetite Score      = 
 
 
 
 
Total Score        = 
 
 
 
Action flowchart 
 
1. Refer to dietician for full assessment and 
intervention 
2. Document 
3. Weigh patients on admission and 
•  weekly (acute) 
•  monthly (long-term care) 
4. Rescreen patients 
•  weekly (acute) 
•  monthly (long-term care) 
Score ≥ 2 → patient at risk of malnutrition 
Fig. 3 MST [22]
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relies on patient literacy, is more time-consuming, and
requires more examiner training than the MST, MNA,
MUST, and the NRS-2002. Nevertheless, the PG-SGA is
deemed to be the “gold standard” in oncology patients. The
MST has been validated in various studies [4, 47, 60, 62]. It
is an appealing choice to screen cancer patients and
consistently demonstrates high sensitivity and specificity.
A routine screening procedure in oncology settings for
early and appropriate identification of malnourished patients
or patients at nutritional risk is an important part of disease
management, and appropriate intervention may lead to
improved outcomes and quality of life [4, 5, 68]. Ravasco et
al. [5] showed in a prospective randomized controlled
interventional trial in 75 head and neck cancer patients that
personalized dietary counseling may prove beneficial, even
having an effect on the final oncologic outcome.
Conclusions
The screening tools presented in this article are fast and
easily applied, and all are validated in mixed populations
and, to a certain extent, also in cancer patients. All the
presented screening tools have been shown to be useful and
to embody the principles of good nutritional screening
described above. Experience shows that it is most important
that cancer patients are screened. The choice of the
appropriate screening tool is important, but the time needed
to complete the screening process will always play a role in
the hospital setting. Once patients at nutritional risk have
been identified, a proactive and early nutritional approach
should constitute an integral part of cancer treatment, with
the intention of improving clinical outcome and quality of
life and reducing health care costs. Furthermore, as shown
in Table 1, there is evidence that certain nutritional
screening tools can help to identify patients at higher risk
for complications and mortality.
In an oncology population, the PG-SGA and the MST
are the tools which have been best validated, but further
research using larger sample sizes for this patient group is
needed. The MST is quicker and easier to use than the PG-
SGA and can be completed by medical, nursing, dietetic, or
administrative staff or by the patients or their family
members. It should be pointed out that there are few
studies that directly link the nutrition process to improved
outcomes in this setting. Routine nutritional screening with
validated tools can identify cancer patients at risk, but we
need further research to evaluate the benefits of nutritional
screening and support and their effect on outcomes.
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